Jennifer Delgado-Santiago
Family · Lake Mary, FLNPI 1194858134
Payments from drug & device makers
Across 236 payments — averaging $29.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$2K
- Sanofi-aventis U.S. LLC$435
- Bayer$384
- Amgen$380
- Lilly USA, LLC$378
- Cequr Corporation$357
- plus $3K from 24 others
What the payments were for
- Speaking & faculty fees$1,80026%
- Food & beverage$5,11474%
- Education$340%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 24 | $2,228 |
| Sanofi-aventis U.S. LLC | 18 | $435 |
| Bayer | 18 | $384 |
| Amgen | 22 | $380 |
| Lilly USA, LLC | 19 | $378 |
| Cequr Corporation | 1 | $357 |
| Xeris Pharmaceuticals, Inc. | 15 | $326 |
| Medtronic | 24 | $313 |
| Boehringer Ingelheim | 13 | $271 |
| Dexcom, Inc. | 9 | $268 |
| Novo Nordisk | 13 | $268 |
| Radius Health, Inc. | 8 | $224 |
| Ascendis Pharma Endocrinology Inc | 5 | $133 |
| Corcept Therapeutics | 6 | $130 |
| BETA Bionics, Inc. | 6 | $114 |
| Amneal Pharmaceuticals LLC | 5 | $107 |
| Renalytix AI, Inc. | 5 | $101 |
| AbbVie | 4 | $83 |
| IBSA Pharma Inc. | 4 | $83 |
| Tandem Diabetes Care, Inc. | 4 | $83 |
| Abiomed | 2 | $51 |
| Amphastar Pharmaceuticals, Inc. | 2 | $47 |
| AstraZeneca | 2 | $42 |
| Averitas Pharma Inc. | 1 | $26 |
| Sequel Med Tech, LLC | 1 | $26 |
| Almatica Pharma LLC | 1 | $23 |
| Tolmar, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$2,025
- CeQur Simplicity$357
- DEXCOM G7 GSS (161)$123
How this compares
$6,948 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 53 | $89,902 |
| JardianceEmpagliflozin | 48 | $64,131 |
| MounjaroTirzepatide | 27 | $30,792 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $28,120 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $21,684 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $17,616 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 33 | $4,078 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,431 |
| SynthroidLevothyroxine Sodium | 12 | $1,355 |
| UnithroidLevothyroxine Sodium | 19 | $572 |
| Levothyroxine Sodium | 18 | $188 |
| Metformin Hcl | 16 | $159 |
| Pioglitazone Hcl | 11 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $268 | $89,90253 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $271 | $81,74760 claims |
| Lilly USA, LLCMounjaro | $378 | $30,79227 claims |
| AbbVieSynthroid | $83 | $1,35512 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $107 | $76037 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in Lake Mary
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.